Symptoms, Tracking, and Critical Warning Signs
At a Glance
PMDD is assessed with daily tracking showing at least five recurring symptoms, including a core emotional symptom, during most cycles; symptoms worsen before menstruation and improve after it begins. Suicidal thoughts require same-day or emergency help.
Diagnosing Premenstrual Dysphoric Disorder (PMDD) involves identifying a specific pattern of symptoms and confirming their cyclical nature. Because PMDD symptoms can look identical to other conditions like clinical depression or anxiety, doctors use standardized criteria and tracking methods to ensure you receive the correct diagnosis and treatment [1][2].
The Symptom Profile
To meet the criteria for PMDD, you must experience at least five symptoms from the following categories during most of your menstrual cycles. Crucially, at least one of these must be a “core” emotional symptom [3][4]:
- Core Emotional Symptoms: Intense mood swings (feeling suddenly sad or tearful), irritability or anger that leads to conflicts, marked depressed mood or feelings of hopelessness, or significant anxiety and tension [1][5].
- Behavioral & Cognitive Symptoms: Decreased interest in usual activities (social, work, hobbies), difficulty concentrating, low energy or easy fatiguability, and changes in appetite (overeating or specific food cravings) [2][5].
- Physical & Control Symptoms: Changes in sleep (sleeping too much or insomnia), feeling overwhelmed or “out of control,” and physical signs like breast tenderness, joint or muscle pain, bloating, or weight gain [4][5].
The Role of Tracking
You may have filled out a retrospective screening questionnaire like the Premenstrual Symptoms Screening Tool (PSST). While these are helpful starting points, they rely on memory and often overdiagnose PMDD, especially in people with underlying depression [1][6]. In one study, retrospective tools flagged 34.6% of participants for PMDD, but only 3.9% were confirmed after daily tracking [6].
This is why prospective daily tracking for at least two symptomatic menstrual cycles is highly recommended by clinical guidelines [7][8]. Using a tool like the Daily Record of Severity of Problems (DRSP) helps prove:
- The Luteal Rise: Symptoms significantly worsen in the week or two before your period starts [5][9].
- The Postmenstrual Improvement: Symptoms become minimal or absent in the week following the start of your period [3][9].
If symptoms are present all month long and simply worsen before your period, you may have Premenstrual Exacerbation (PME) of an underlying condition [10][11]. Note that PMDD and PME can coexist, and you do not need to wait two months to receive initial support, safety planning, and provisional treatment.
Critical Warning Signs and Safety
PMDD is associated with a significantly increased risk of suicidal ideation (thoughts of suicide) and self-harm [12][13]. Population-level observational studies suggest that people with PMDD may have nearly seven times the odds of a suicide attempt compared to those without the condition [12]. While this statistic highlights an average association and is not a guaranteed personal prediction, it underscores how intensely the condition can impact mental health. These symptoms often surge during the luteal phase [13][14].
Urgent and Emergency Action Plan
Any suicidal thoughts warrant prompt assessment. Never wait until your next scheduled appointment to report them. The distinction between “passive” and “active” thoughts can blur quickly during a PMDD crisis.
- When to seek immediate EMERGENCY care: If you experience active thoughts of suicide, a specific plan, intent, an escalating urge, or an inability to keep yourself safe, go to the nearest emergency department or call emergency services immediately [15][16]. Do not stay alone. Remove or distance yourself from access to lethal means.
- When to seek SAME-DAY care: If you are experiencing thoughts of death or self-harm but do not currently have a plan or intent, contact your clinician, a crisis service, or an urgent mental-health service that same day.
Crisis Resources:
- United States & Canada: Call or text 988 to reach the Suicide & Crisis Lifeline.
- International: Please utilize your country’s local equivalent emergency number or crisis hotline.
Before your next luteal phase, work with your care team to develop a written safety plan that includes warning signs, emergency contacts, and steps to reduce access to means [12][17].
Common questions in this guide
What symptoms are needed for a PMDD diagnosis?
How long should I track my symptoms to check for PMDD?
How can I tell PMDD from premenstrual exacerbation?
Does a positive PMDD screening questionnaire confirm the diagnosis?
What should I do if PMDD causes suicidal thoughts?
How can I prepare for a difficult premenstrual phase?
Appointments are short. Make every minute count.
Specialist visits move fast. Let us help you prep so your time goes to what matters.
About tracking
Would daily symptom tracking using the DRSP be needed before a diagnosis?
Symptom patterns
Could my symptoms be a worsening of an existing condition rather than PMDD?
Criteria and symptoms
Does at least one symptom need to be a core emotional one to meet the criteria?
Get notified when new evidence is published on premenstrual tension.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (17)
- 1
Toward the Reliable Diagnosis of DSM-5 Premenstrual Dysphoric Disorder: The Carolina Premenstrual Assessment Scoring System (C-PASS).
Eisenlohr-Moul TA, Girdler SS, Schmalenberger KM, et al.
The American journal of psychiatry 2017; (174(1)):51-59 doi:10.1176/appi.ajp.2016.15121510.
PMID: 27523500 - 2
Psychometric Properties of a DSM-5-Based Screening Tool for Women's Perceptions of Premenstrual Symptoms.
Richards MA, Oinonen KA
Psychological reports 2022; (125(2)):1186-1217 doi:10.1177/0033294120979696.
PMID: 33583248 - 3
The multifactorial aetiology and management of premenstrual dysphoric disorder with leuprorelin acetate.
Dunphy L, Boyle S, Wood F
BMJ case reports 2023; (16(12)) doi:10.1136/bcr-2023-258343.
PMID: 38160030 - 4
Significance and Interrelationship of the Symptoms Listed in the DSM Criteria for Premenstrual Dysphoric Disorder.
Studer E, Nilsson S, Westman A, et al.
Psychiatric research and clinical practice 2023; (5(3)):105-113 doi:10.1176/appi.prcp.20220007.
PMID: 37711753 - 5
Contraception counseling for women with premenstrual dysphoric disorder (PMDD): current perspectives.
Rapkin AJ, Korotkaya Y, Taylor KC
Open access journal of contraception 2019; (10()):27-39 doi:10.2147/OAJC.S183193.
PMID: 31572029 - 6
Premenstrual Syndrome Diagnosis: A Comparative Study between the Daily Record of Severity of Problems (DRSP) and the Premenstrual Symptoms Screening Tool (PSST).
Henz A, Ferreira CF, Oderich CL, et al.
Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia 2018; (40(1)):20-25 doi:10.1055/s-0037-1608672.
PMID: 29132173 - 7
The prevalence of premenstrual dysphoric disorder: Systematic review and meta-analysis.
Reilly TJ, Patel S, Unachukwu IC, et al.
Journal of affective disorders 2024; (349()):534-540 doi:10.1016/j.jad.2024.01.066.
PMID: 38199397 - 8
The pharmacotherapeutic management of premenstrual dysphoric disorder.
Ciccone N, Kovacheff MB, Frey BN
Expert opinion on pharmacotherapy 2023; (24(1)):145-151 doi:10.1080/14656566.2022.2114345.
PMID: 35974667 - 9
Are there temporal subtypes of premenstrual dysphoric disorder?: using group-based trajectory modeling to identify individual differences in symptom change.
Eisenlohr-Moul TA, Kaiser G, Weise C, et al.
Psychological medicine 2020; (50(6)):964-972 doi:10.1017/S0033291719000849.
PMID: 31010447 - 10
Gold-standard evidence and best practice guidance for menstrual cycle-informed clinical care: An overview for clinicians.
Lambert ER, Nolan LN, Schmalenberger KM
The British journal of clinical psychology 2026; doi:10.1111/bjc.70066.
PMID: 42162940 - 11
The Influence of Depression on Biased Diagnosis of Premenstrual Syndrome and Premenstrual Dysphoric Disorder by the PSST Inventory.
Śliwerski A, Koszałkowska K
Life (Basel, Switzerland) 2021; (11(11)) doi:10.3390/life11111278.
PMID: 34833154 - 12
Suicidal Risk in Women with Premenstrual Syndrome and Premenstrual Dysphoric Disorder: A Systematic Review and Meta-Analysis.
Prasad D, Wollenhaupt-Aguiar B, Kidd KN, et al.
Journal of women's health (2002) 2021; (30(12)):1693-1707 doi:10.1089/jwh.2021.0185.
PMID: 34415776 - 13
Prevalence and correlates of current suicidal ideation in women with premenstrual dysphoric disorder.
Wikman A, Sacher J, Bixo M, et al.
BMC women's health 2022; (22(1)):35 doi:10.1186/s12905-022-01612-5.
PMID: 35148753 - 14
Prospective daily evidence of cyclic suicidality and self-harm in premenstrual disorders.
Ly M, Zorzini G, Wahl T, et al.
Psychoneuroendocrinology 2026; (191()):107949 doi:10.1016/j.psyneuen.2026.107949.
PMID: 42391968 - 15
Prevalence of lifetime self-injurious thoughts and behaviors in a global sample of 599 patients reporting prospectively confirmed diagnosis with premenstrual dysphoric disorder.
Eisenlohr-Moul T, Divine M, Schmalenberger K, et al.
BMC psychiatry 2022; (22(1)):199 doi:10.1186/s12888-022-03851-0.
PMID: 35303811 - 16
Factors associated with suicide risk in young women with premenstrual dysphoric disorder: a population-based study.
Machado FZ, da Mota MSS, Dos Santos EP, et al.
Trends in psychiatry and psychotherapy 2025; (47()):e20230718 doi:10.47626/2237-6089-2023-0718.
PMID: 38315812 - 17
Premenstrual disorders and PMDD - a review.
Cary E, Simpson P
Best practice & research. Clinical endocrinology & metabolism 2024; (38(1)):101858 doi:10.1016/j.beem.2023.101858.
PMID: 38182436
This page is for informational purposes only and does not constitute medical advice. Use it to prepare for a conversation with your clinician; any suicidal thoughts require prompt assessment, and an immediate safety risk requires emergency care.